Literature DB >> 18995950

Neoadjuvant chemotherapy: a new treatment paradigm for muscle-invasive bladder cancer.

Harry W Herr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18995950     DOI： 10.1016/j.eururo.2008.10.033

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  4 in total

1.  Perioperative chemotherapy for muscle-invasive bladder cancer.

Authors:  Peter Black; Alan So
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

2.  Partial Cystectomy after Neoadjuvant Chemotherapy: Memorial Sloan Kettering Cancer Center Contemporary Experience.

Authors:  Wassim M Bazzi; Ryan P Kopp; Timothy F Donahue; Melanie Bernstein; Paul Russo; Bernard H Bochner; Sherri M Donat; Guido Dalbagni; Harry W Herr
Journal:  Int Sch Res Notices       Date:  2014-11-13

3.  Oncologic Outcomes and Predictive Factors for Recurrence Following Robot-Assisted Radical Cystectomy for Urothelial Carcinoma: Multicenter Study from Korea.

Authors:  Ji Sung Shim; Tae Gyun Kwon; Koon Ho Rha; Young Goo Lee; Ji Youl Lee; Byong Chang Jeong; Jae Yoon Kim; Jong Hyun Pyun; Sung Gu Kang; Seok Ho Kang
Journal:  J Korean Med Sci       Date:  2017-10       Impact factor: 2.153

4.  Neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer: The likelihood of initiation and completion.

Authors:  Ahmed Eldefrawy; Mark S Soloway; Devendar Katkoori; Rakesh Singal; David Pan; Murugesan Manoharan
Journal:  Indian J Urol       Date:  2012-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.